Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

January 4, 2016

Zipnosis: Empowering health systems to launch their own branded virtual care service lines

To kick-off the new year, we’re excited to announce a new partner company—Zipnosis. Safeguard led Zipnosis’ $17 million Series A financing with participation from Ascension Ventures, a subsidiary…

Posted by Al Wiegman

CloudMine Series A Financing March 12, 2015

CloudMine: Fueling the transformation of how people consume and interact with enterprise data

We are excited to welcome CloudMine to the Safeguard family. We believe that Brendan McCorkle, Marc Weil, Jay Hershman and the rest of the team…

Posted by David Luk

July 1, 2011

Week in Review: Google Goes Social and Shire Completes ABH Acquisition

What a week it’s been for Safeguard Scientifics and our partner companies. But before we get into those details, let’s recap some of the big news…

Posted by John E. Shave III

June 27, 2011

Safeguard Scientifics Leads $35 Million Financing for NovaSom

Baltimore-based company provides home sleep tests for the diagnosis of obstructive sleep apnea Wayne, PA, June 27, 2011 – Safeguard Scientifics, Inc. (NYSE: SFE), a holding…

Posted by James A. Datin

September 10, 2010

Advancements in Diagnostics

Advances in the life sciences will continue to have a far-reaching impact on virtually every aspect of our society. There is an abundance of companies…

Posted by James A. Datin

March 31, 2010

Avid Radiopharmaceuticals Making Strides Toward Clinical Trial Milestone

I frequently attribute Safeguard Scientifics’ success to our disciplined strategy built on five strategic themes, which we refer to as M2C3. We leverage these themes…

Posted by Peter J. Boni

February 22, 2010

Molecular Biometrics Attracts Another $12.5 Million

Molecular Biometrics, Inc., one of Safeguard Scientifics’ Life Sciences partner companies, raised another $12.5 million of capital. The new capital will support three big goals.…

Posted by John E. Shave III

Content